查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
失眠全球市场规模、份额和行业趋势分析报告：按分销渠道（医院、零售、其他）、治疗类型（药物、非药物）、区域展望和预测2022-2028
市场调查报告书
商品编码
1150349

失眠全球市场规模、份额和行业趋势分析报告：按分销渠道（医院、零售、其他）、治疗类型（药物、非药物）、区域展望和预测2022-2028

Global Insomnia Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Hospital, Retail, and Others), By Therapy Type (Pharmacological and Non-Pharmacological), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 149 Pages | 订单完成后即时交付

价格

在预测期内，全球失眠市场规模预计将以 3.9% 的复合年增长率增长，到 2028 年将达到 57 亿美元。

由于工作相关压力的增加，失眠市场正在增长。增加的工作量和苛刻的工作时间表会导致睡眠不足。此外，包括保安人员在内的许多人都在不定期轮班工作，并且生产全天候开放。这些不规律的轮班会影响睡眠的质量和节奏。近年来，睡眠诊断和失眠症中心的数量也有所增加。失眠中心帮助人们获得更好的睡眠质量，睡眠障碍中心充当诊断实验室。

COVID-19 影响分析

COVID-19的爆发有望利好失眠药物的市场拓展。 Covid-19 大流行使行业陷入瘫痪，使许多工人失业，并加剧了社会压力水平。其他人则因害怕大流行病而患上抑郁症。因此，预计 COVID-19 大流行将增加因压力和抑郁引起的失眠的发生率，增加对失眠药物的需求并扩大市场。

市场增长因素

人口老龄化加剧

研究表明，老年人（65 岁以上）患某些类型癌症的可能性是年轻人的 11 倍。未来 20 年，随着世界人口老龄化，老年人的癌症发病率预计会增加。屈光不正、白内障、睡眠问题和听力损失在老年人中都很常见。在全球范围内，许多老年人都有睡眠问题。因此，预计人口老龄化将导致失眠病例数量增加，进一步推动预测期内失眠市场的增长。

不断上涨的医疗费用

由于对治疗方案的认识提高，医疗保健成本上升和疾病的早期诊断预计将成为预测期内推动市场增长的因素。政府在医疗保健行业投资的规模和数量不断增加也是推动市场增长的关键因素之一。随着 COVID-19 大流行的开始，许多政府加大了对建设医疗保健系统的投资。随着大流行的影响减弱，各家医院都将这些资源集中在治疗其他严重疾病上。由于医疗保健投资的增加，失眠市场正在增长。

市场製约因素

诊断和治疗失眠的费用

诊断和治疗失眠症的高成本是阻碍失眠症市场增长的主要因素之一。 “睡眠障碍”一词还包括一系列对个人健康有重大负面影响并产生高社会成本的疾病。失眠使人难以过上正常的生活，经济和医疗负担也很大，许多患者甚至会完全残疾。失眠患者每年直接在医疗保健上的花费是无症状对照组的两倍左右。由于药价高，失眠市场没有增长。

按分销渠道划分的前景

失眠药物市场按分销渠道分为医院、零售和其他。 2021 年，零售部门在失眠市场的销售额中占据了相当大的份额。由于各种零售店广泛供应睡眠障碍治疗药，这一领域的市场正在增长。此外，人们对失眠等疾病后果的认识不断提高，也推动了这一市场的发展。政府还支持在这些商店出售的安眠药。

治疗类型的前景

根据治疗类型，失眠市场分为非药物疗法和药物疗法。 2021年，药物治疗板块主导失眠市场，收入占比最大。这是由于失眠症患病率的上升以及失眠药物的主要製造商数量的增加。失眠药物和安眠药的存在正在全世界蔓延。在这个领域，由于世界各地有许多市场参与者，市场规模正在增长。

区域概览

按地区分析了北美、欧洲、亚太地区和 LAMEA 的失眠市场。 2021 年，北美地区在失眠市场的收入份额最高。这是由于医疗保健系统的发展，包括失眠症患病率增加、工作压力大以及该地区失眠中心的存在。慢性肾病患者数量的增加以及该地区大量失眠诊所的存在预计也将推动市场增长。

内容

第一章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场规模
  • 细分
    • 全球失眠市场，按分销渠道
    • 全球失眠市场，按治疗类型
    • 全球失眠市场，按地区
  • 调查方法

第 2 章市场概述

  • 简介
    • 概览
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场製约因素

第 3 章失眠市场部署的策略

第 4 章全球失眠市场：按分销渠道

  • 全球医院市场：按地区
  • 全球零售市场：按地区
  • 全球各地区的其他市场

第 5 章全球失眠市场：按治疗类型分类

  • 全球药物治疗市场：按地区
  • 全球非药物疗法市场：按地区

第 6 章全球失眠市场：按地区

  • 北美
    • 按国家/地区划分的北美失眠市场
      • 美国
      • 加拿大
      • 墨西哥
      • 北美以外的地区
  • 欧洲
    • 欧洲失眠市场：按国家/地区分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲
  • 亚太地区
    • 按国家/地区划分的亚太地区失眠市场
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • 拉美
    • LAMEA 失眠症市场：按国家/地区分类
      • 巴西
      • 阿根廷
      • 阿联酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 其他拉美地区

第七章公司简介

  • Eisai Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Vanda Pharmaceuticals, Inc.
  • Cadila Healthcare Ltd.（Zydus Cadila）
  • Sanofi S.A
  • Merck Group
  • Pfizer, Inc.
  • Viatris, Inc.
  • Currax Pharmaceuticals LLC（Currax Holdings USA LLC）
  • Purdue Pharma L.P

The Global Insomnia Market size is expected to reach $5.7 billion by 2028, rising at a market growth of 3.9% CAGR during the forecast period.

A common sleep disorder called insomnia can make it difficult to fall asleep, stay asleep, or wake up early and have trouble falling back asleep. Stress, bad sleeping habits, irregular sleep schedules, mental health conditions like physical illnesses and pain, anxiety and depression, medications, neurological issues, and specific sleep disorders are some of the common causes of insomnia.

The rise in the prevalence of distinct sleep disorders, including parasomnias as well as insomnia, and the rise in mental depression and other painful conditions, are the main factors driving the growth of the insomnia market size. Sleep issues are a result of mental depression. As a result, an increase in mental depression among the general population contributes to the growth of the insomnia market. Furthermore, taking some medications for a chronic condition over an extended period of time has some side effects that are thought to impair a patient's ability to sleep.

Additionally, the market for insomnia is expanding due to an increase in work-related stress. The increased workload and demanding work schedules result in poor sleep. Additionally, a lot of people including security guards work odd shifts, and the manufacturing sector is open around-the-clock. The quality and rhythm of sleep are impacted by these irregular work shifts. Also, a rise in the number of sleep diagnostics and centres for people with insomnia helps has been seen in the past few years. The centres for insomnia help people get better quality sleep, and the centres for sleep disorders are utilized as diagnostic testing facilities.

COVID-19 Impact Analysis

It is anticipated that the COVID-19 outbreak will benefit the expansion of the market for insomniac remedies. Due to improperly functioning industries brought on by the COVID-19 pandemic, many workers lost their jobs, which contributed to an increase in stress levels in society. Additionally, some people around the world developed depression as a result of pandemic fear. As a result, the COVID-19 pandemic's increased incidence of insomnia a condition marked by stress and depression boosts the demand for drugs that treat insomnia and propel the market's expansion.

Market Growth Factors

Increasing Aging Population

According to studies, older people (defined as those 65 and older) appear to have an 11-fold increased risk of developing some types of cancer than younger people. The burden of cancer among the elderly would then increase as the world population ages over the following 20 years. Refractive errors, cataracts, sleep issues, and hearing loss are all fairly common in older people. A large ratio of old age people is facing sleeping issues worldwide. Thus, the rise in the aging population would result in an increasing number of insomnia cases which would further support the growth of the insomnia market over the forecast period.

Increasing Healthcare Costs

Rising healthcare costs and earlier disease diagnosis because of greater awareness of treatment options are factors that are anticipated to fuel the market growth over the course of the forecast period. The increasing size and number of funds invested in the healthcare industry by governments of different countries are one of the primary drivers of the market's growth. Governments from a number of nations boosted their investments in creating healthcare systems whenever the COVID-19 pandemic first started to spread. As the pandemic's impact lessens, various hospitals are now concentrating on using these resources to treat other severe diseases. The insomnia market is expanding as a result of rising healthcare investment.

Market Restraining Factors

High Cost Of Diagnosing And Treating Insomnia

The high cost of diagnosis and treatment is one of the major factors impeding the growth of the insomnia market. Additionally, the term "sleeping problem" covers a wide range of illnesses that have significant detrimental effects on an individual's health and incur high societal costs. Insomnia makes it difficult to carry out daily tasks and is associated with a heavy financial & medical burden many patients are completely disabled. Insomnia patients spent about two times as much on direct medical care each year as matched controls without condition. The market for insomnia is not expanding because of the high cost of the medication.

Distribution Channel Outlook

By distribution channel, the insomnia market is divided into hospital, retail and others. The retail segment recorded a substantial revenue share in the insomnia market in 2021. The market in this segment is growing as a result of the wide availability of pills for treatment of sleeping disorder in various retail stores. In addition, the market is also growing due to rising awareness of consequences of diseases such as insomnia. Also, the government is supporting the medicines for condition to be marketed in such stores.

Therapy Type Outlook

Based on therapy type, the insomnia market is segmented into non-pharmacological therapy, pharmacological therapy. In 2021, the pharmacological therapy segment dominated the insomnia market with the maximum revenue share. This is due to the rising prevalence of insomnia and the growing number of major manufacturers of therapeutic drugs for insomnia. The presence of pills for insomnia treatment and sleeping pills is wide all over the world. The market is expanding in this segment as a result of a large number of market players present all over the world.

Regional Outlook

Region wise, the insomnia market is analyzed across the North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region held the highest revenue share in the insomnia market. This is due to an increase in the prevalence of insomnia, a high incidence of stress at work, and a developed healthcare system, including the presence of insomnia centers in the region. Additionally, a rise in the number of patients suffering from chronic renal and kidney illnesses as well as the existence of a sizable number of insomnia clinics in this region are predicted to fuel market growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Eisai Co., Ltd., Merck Group, Pfizer, Inc., Vanda Pharmaceuticals, Inc., Cadila Healthcare Ltd. (Zydus Cadila), Sanofi S.A., Viatris, Inc., Takeda Pharmaceutical Company Limited, and Purdue Pharma L.P.

Strategies deployed in Insomnia Market

Oct-2021: Currax expanded its geographical footprints in Brentwood by opening HQ in the region. This expansion aimed at expanding access to medicines, both generic and brand name.

Dec-2020: Vanda Pharmaceuticals got FDA approval for the HETLIOZ capsule & liquid formulation, the first FDA-approved medication for patients with SMS. The product would be used for the treatment of adults & children, respectively, with nighttime sleep disturbances associated with Smith-Magenis Syndrome (SMS).

Jun-2020: Sanofi expanded its geographical footprint in India. This expansion focused on producing Amaryl & Daonil tablets for blood glucose reduction, Frisium for seizures, and Stilnoct for insomnia in the region.

Jun-2020: Eisai launched DAYVIGO CIV, the in-house discovered orexin receptor antagonist. This launch would address adults with insomnia, characterized by difficulties with sleep onset and sleep maintenance.

Dec-2019: Eisai got FDA approval for DAYVIGO. Through this approval, DAYVIGO would be commercially available in 5 mg and 10 mg tablets following scheduling by the U.S. Drug Enforcement Administration (DEA), which is expected to occur within 90 days.

Sep-2019: Currax signed an agreement to acquire Nalpropion Pharmaceuticals, a biopharmaceutical company focused on the treatment of weight loss. This acquisition enables Currax to own the worldwide rights to CONTRAVE, one of the most prescribed weight-loss brand medications in the US.

Sep-2019: Takeda and Lundbeck got Labour and Welfare (MHLW) approval of Trintellix. By this approval, Trintellix would be able to provide the treatment of depression and depressed state.

Jul-2019: Zydus Cadila introduced Ramelteon tablets, USFDA-approved capsules used to treat insomnia. Ramelteon would be used in the treatment of insomnia associated with having trouble falling asleep.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Hospital
  • Retail
  • Others

By Therapy Type

  • Pharmacological
  • Non-Pharmacological

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
  • Eisai Co., Ltd.
  • Merck Group
  • Pfizer, Inc.
  • Vanda Pharmaceuticals, Inc.
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Sanofi S.A.
  • Viatris, Inc.
  • Takeda Pharmaceutical Company Limited
  • Purdue Pharma L.P.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Insomnia Market, by Distribution Channel
    • 1.4.2 Global Insomnia Market, by Therapy Type
    • 1.4.3 Global Insomnia Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Insomnia Market

Chapter 4. Global Insomnia Market by Distribution Channel

  • 4.1 Global Hospital Market by Region
  • 4.2 Global Retail Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Insomnia Market by Therapy Type

  • 5.1 Global Pharmacological Market by Region
  • 5.2 Global Non-Pharmacological Market by Region

Chapter 6. Global Insomnia Market by Region

  • 6.1 North America Insomnia Market
    • 6.1.1 North America Insomnia Market by Distribution Channel
      • 6.1.1.1 North America Hospital Market by Country
      • 6.1.1.2 North America Retail Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Insomnia Market by Therapy Type
      • 6.1.2.1 North America Pharmacological Market by Country
      • 6.1.2.2 North America Non-Pharmacological Market by Country
    • 6.1.3 North America Insomnia Market by Country
      • 6.1.3.1 US Insomnia Market
        • 6.1.3.1.1 US Insomnia Market by Distribution Channel
        • 6.1.3.1.2 US Insomnia Market by Therapy Type
      • 6.1.3.2 Canada Insomnia Market
        • 6.1.3.2.1 Canada Insomnia Market by Distribution Channel
        • 6.1.3.2.2 Canada Insomnia Market by Therapy Type
      • 6.1.3.3 Mexico Insomnia Market
        • 6.1.3.3.1 Mexico Insomnia Market by Distribution Channel
        • 6.1.3.3.2 Mexico Insomnia Market by Therapy Type
      • 6.1.3.4 Rest of North America Insomnia Market
        • 6.1.3.4.1 Rest of North America Insomnia Market by Distribution Channel
        • 6.1.3.4.2 Rest of North America Insomnia Market by Therapy Type
  • 6.2 Europe Insomnia Market
    • 6.2.1 Europe Insomnia Market by Distribution Channel
      • 6.2.1.1 Europe Hospital Market by Country
      • 6.2.1.2 Europe Retail Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Insomnia Market by Therapy Type
      • 6.2.2.1 Europe Pharmacological Market by Country
      • 6.2.2.2 Europe Non-Pharmacological Market by Country
    • 6.2.3 Europe Insomnia Market by Country
      • 6.2.3.1 Germany Insomnia Market
        • 6.2.3.1.1 Germany Insomnia Market by Distribution Channel
        • 6.2.3.1.2 Germany Insomnia Market by Therapy Type
      • 6.2.3.2 UK Insomnia Market
        • 6.2.3.2.1 UK Insomnia Market by Distribution Channel
        • 6.2.3.2.2 UK Insomnia Market by Therapy Type
      • 6.2.3.3 France Insomnia Market
        • 6.2.3.3.1 France Insomnia Market by Distribution Channel
        • 6.2.3.3.2 France Insomnia Market by Therapy Type
      • 6.2.3.4 Russia Insomnia Market
        • 6.2.3.4.1 Russia Insomnia Market by Distribution Channel
        • 6.2.3.4.2 Russia Insomnia Market by Therapy Type
      • 6.2.3.5 Spain Insomnia Market
        • 6.2.3.5.1 Spain Insomnia Market by Distribution Channel
        • 6.2.3.5.2 Spain Insomnia Market by Therapy Type
      • 6.2.3.6 Italy Insomnia Market
        • 6.2.3.6.1 Italy Insomnia Market by Distribution Channel
        • 6.2.3.6.2 Italy Insomnia Market by Therapy Type
      • 6.2.3.7 Rest of Europe Insomnia Market
        • 6.2.3.7.1 Rest of Europe Insomnia Market by Distribution Channel
        • 6.2.3.7.2 Rest of Europe Insomnia Market by Therapy Type
  • 6.3 Asia Pacific Insomnia Market
    • 6.3.1 Asia Pacific Insomnia Market by Distribution Channel
      • 6.3.1.1 Asia Pacific Hospital Market by Country
      • 6.3.1.2 Asia Pacific Retail Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Insomnia Market by Therapy Type
      • 6.3.2.1 Asia Pacific Pharmacological Market by Country
      • 6.3.2.2 Asia Pacific Non-Pharmacological Market by Country
    • 6.3.3 Asia Pacific Insomnia Market by Country
      • 6.3.3.1 China Insomnia Market
        • 6.3.3.1.1 China Insomnia Market by Distribution Channel
        • 6.3.3.1.2 China Insomnia Market by Therapy Type
      • 6.3.3.2 Japan Insomnia Market
        • 6.3.3.2.1 Japan Insomnia Market by Distribution Channel
        • 6.3.3.2.2 Japan Insomnia Market by Therapy Type
      • 6.3.3.3 India Insomnia Market
        • 6.3.3.3.1 India Insomnia Market by Distribution Channel
        • 6.3.3.3.2 India Insomnia Market by Therapy Type
      • 6.3.3.4 South Korea Insomnia Market
        • 6.3.3.4.1 South Korea Insomnia Market by Distribution Channel
        • 6.3.3.4.2 South Korea Insomnia Market by Therapy Type
      • 6.3.3.5 Singapore Insomnia Market
        • 6.3.3.5.1 Singapore Insomnia Market by Distribution Channel
        • 6.3.3.5.2 Singapore Insomnia Market by Therapy Type
      • 6.3.3.6 Malaysia Insomnia Market
        • 6.3.3.6.1 Malaysia Insomnia Market by Distribution Channel
        • 6.3.3.6.2 Malaysia Insomnia Market by Therapy Type
      • 6.3.3.7 Rest of Asia Pacific Insomnia Market
        • 6.3.3.7.1 Rest of Asia Pacific Insomnia Market by Distribution Channel
        • 6.3.3.7.2 Rest of Asia Pacific Insomnia Market by Therapy Type
  • 6.4 LAMEA Insomnia Market
    • 6.4.1 LAMEA Insomnia Market by Distribution Channel
      • 6.4.1.1 LAMEA Hospital Market by Country
      • 6.4.1.2 LAMEA Retail Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Insomnia Market by Therapy Type
      • 6.4.2.1 LAMEA Pharmacological Market by Country
      • 6.4.2.2 LAMEA Non-Pharmacological Market by Country
    • 6.4.3 LAMEA Insomnia Market by Country
      • 6.4.3.1 Brazil Insomnia Market
        • 6.4.3.1.1 Brazil Insomnia Market by Distribution Channel
        • 6.4.3.1.2 Brazil Insomnia Market by Therapy Type
      • 6.4.3.2 Argentina Insomnia Market
        • 6.4.3.2.1 Argentina Insomnia Market by Distribution Channel
        • 6.4.3.2.2 Argentina Insomnia Market by Therapy Type
      • 6.4.3.3 UAE Insomnia Market
        • 6.4.3.3.1 UAE Insomnia Market by Distribution Channel
        • 6.4.3.3.2 UAE Insomnia Market by Therapy Type
      • 6.4.3.4 Saudi Arabia Insomnia Market
        • 6.4.3.4.1 Saudi Arabia Insomnia Market by Distribution Channel
        • 6.4.3.4.2 Saudi Arabia Insomnia Market by Therapy Type
      • 6.4.3.5 South Africa Insomnia Market
        • 6.4.3.5.1 South Africa Insomnia Market by Distribution Channel
        • 6.4.3.5.2 South Africa Insomnia Market by Therapy Type
      • 6.4.3.6 Nigeria Insomnia Market
        • 6.4.3.6.1 Nigeria Insomnia Market by Distribution Channel
        • 6.4.3.6.2 Nigeria Insomnia Market by Therapy Type
      • 6.4.3.7 Rest of LAMEA Insomnia Market
        • 6.4.3.7.1 Rest of LAMEA Insomnia Market by Distribution Channel
        • 6.4.3.7.2 Rest of LAMEA Insomnia Market by Therapy Type

Chapter 7. Company Profiles

  • 7.1 Eisai Co., Ltd.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Product Launches and Product Expansions:
      • 7.1.5.2 Approvals and Trails:
  • 7.2 Takeda Pharmaceutical Company Limited
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Approvals and Trails:
  • 7.3 Vanda Pharmaceuticals, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Research & Development Expenses
    • 7.3.4 Recent strategies and developments:
      • 7.3.4.1 Approval and Trails:
  • 7.4 Cadila Healthcare Ltd. (Zydus Cadila)
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Product Launches and Product Expansions:
  • 7.5 Sanofi S.A.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Geographical Expansions:
  • 7.6 Merck Group
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
  • 7.7 Pfizer, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional & Segmental Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Viatris, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
    • 7.9.1 Company Overview
    • 7.9.2 Recent strategies and developments:
      • 7.9.2.1 Acquisition and Mergers:
      • 7.9.2.2 Geographical Expansions:
  • 7.10. Purdue Pharma L.P.
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Insomnia Market, 2018 - 2021, USD Million
  • TABLE 2 Global Insomnia Market, 2022 - 2028, USD Million
  • TABLE 3 Global Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 4 Global Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 5 Global Hospital Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Hospital Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Retail Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Retail Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 12 Global Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 13 Global Pharmacological Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Pharmacological Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Non-Pharmacological Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Non-Pharmacological Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Insomnia Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Insomnia Market by Region, 2022 - 2028, USD Million
  • TABLE 19 North America Insomnia Market, 2018 - 2021, USD Million
  • TABLE 20 North America Insomnia Market, 2022 - 2028, USD Million
  • TABLE 21 North America Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 22 North America Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 23 North America Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 24 North America Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 25 North America Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 26 North America Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 27 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 30 North America Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 31 North America Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 37 US Insomnia Market, 2018 - 2021, USD Million
  • TABLE 38 US Insomnia Market, 2022 - 2028, USD Million
  • TABLE 39 US Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 40 US Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 41 US Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 42 US Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 43 Canada Insomnia Market, 2018 - 2021, USD Million
  • TABLE 44 Canada Insomnia Market, 2022 - 2028, USD Million
  • TABLE 45 Canada Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 46 Canada Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 47 Canada Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 48 Canada Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 49 Mexico Insomnia Market, 2018 - 2021, USD Million
  • TABLE 50 Mexico Insomnia Market, 2022 - 2028, USD Million
  • TABLE 51 Mexico Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 52 Mexico Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 53 Mexico Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 54 Mexico Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 55 Rest of North America Insomnia Market, 2018 - 2021, USD Million
  • TABLE 56 Rest of North America Insomnia Market, 2022 - 2028, USD Million
  • TABLE 57 Rest of North America Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 58 Rest of North America Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 59 Rest of North America Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 60 Rest of North America Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 61 Europe Insomnia Market, 2018 - 2021, USD Million
  • TABLE 62 Europe Insomnia Market, 2022 - 2028, USD Million
  • TABLE 63 Europe Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 64 Europe Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 65 Europe Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 66 Europe Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 67 Europe Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 68 Europe Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 69 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 70 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 71 Europe Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 72 Europe Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 73 Europe Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 74 Europe Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 75 Europe Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 76 Europe Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 77 Europe Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Germany Insomnia Market, 2018 - 2021, USD Million
  • TABLE 80 Germany Insomnia Market, 2022 - 2028, USD Million
  • TABLE 81 Germany Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 82 Germany Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 83 Germany Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 84 Germany Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 85 UK Insomnia Market, 2018 - 2021, USD Million
  • TABLE 86 UK Insomnia Market, 2022 - 2028, USD Million
  • TABLE 87 UK Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 88 UK Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 89 UK Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 90 UK Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 91 France Insomnia Market, 2018 - 2021, USD Million
  • TABLE 92 France Insomnia Market, 2022 - 2028, USD Million
  • TABLE 93 France Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 94 France Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 95 France Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 96 France Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 97 Russia Insomnia Market, 2018 - 2021, USD Million
  • TABLE 98 Russia Insomnia Market, 2022 - 2028, USD Million
  • TABLE 99 Russia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 100 Russia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 101 Russia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 102 Russia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 103 Spain Insomnia Market, 2018 - 2021, USD Million
  • TABLE 104 Spain Insomnia Market, 2022 - 2028, USD Million
  • TABLE 105 Spain Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 106 Spain Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 107 Spain Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 108 Spain Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 109 Italy Insomnia Market, 2018 - 2021, USD Million
  • TABLE 110 Italy Insomnia Market, 2022 - 2028, USD Million
  • TABLE 111 Italy Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 112 Italy Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 113 Italy Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 114 Italy Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 115 Rest of Europe Insomnia Market, 2018 - 2021, USD Million
  • TABLE 116 Rest of Europe Insomnia Market, 2022 - 2028, USD Million
  • TABLE 117 Rest of Europe Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 118 Rest of Europe Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 119 Rest of Europe Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 120 Rest of Europe Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 121 Asia Pacific Insomnia Market, 2018 - 2021, USD Million
  • TABLE 122 Asia Pacific Insomnia Market, 2022 - 2028, USD Million
  • TABLE 123 Asia Pacific Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 124 Asia Pacific Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 125 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 126 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 127 Asia Pacific Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 128 Asia Pacific Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 129 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Asia Pacific Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 132 Asia Pacific Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 133 Asia Pacific Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Asia Pacific Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Asia Pacific Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 136 Asia Pacific Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 137 Asia Pacific Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 138 Asia Pacific Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 139 China Insomnia Market, 2018 - 2021, USD Million
  • TABLE 140 China Insomnia Market, 2022 - 2028, USD Million
  • TABLE 141 China Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 142 China Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 143 China Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 144 China Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 145 Japan Insomnia Market, 2018 - 2021, USD Million
  • TABLE 146 Japan Insomnia Market, 2022 - 2028, USD Million
  • TABLE 147 Japan Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 148 Japan Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 149 Japan Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 150 Japan Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 151 India Insomnia Market, 2018 - 2021, USD Million
  • TABLE 152 India Insomnia Market, 2022 - 2028, USD Million
  • TABLE 153 India Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 154 India Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 155 India Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 156 India Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 157 South Korea Insomnia Market, 2018 - 2021, USD Million
  • TABLE 158 South Korea Insomnia Market, 2022 - 2028, USD Million
  • TABLE 159 South Korea Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 South Korea Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 South Korea Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 162 South Korea Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 163 Singapore Insomnia Market, 2018 - 2021, USD Million
  • TABLE 164 Singapore Insomnia Market, 2022 - 2028, USD Million
  • TABLE 165 Singapore Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 166 Singapore Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 167 Singapore Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 168 Singapore Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 169 Malaysia Insomnia Market, 2018 - 2021, USD Million
  • TABLE 170 Malaysia Insomnia Market, 2022 - 2028, USD Million
  • TABLE 171 Malaysia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 172 Malaysia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 173 Malaysia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 174 Malaysia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 175 Rest of Asia Pacific Insomnia Market, 2018 - 2021, USD Million
  • TABLE 176 Rest of Asia Pacific Insomnia Market, 2022 - 2028, USD Million
  • TABLE 177 Rest of Asia Pacific Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 178 Rest of Asia Pacific Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 179 Rest of Asia Pacific Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 180 Rest of Asia Pacific Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 181 LAMEA Insomnia Market, 2018 - 2021, USD Million
  • TABLE 182 LAMEA Insomnia Market, 2022 - 2028, USD Million
  • TABLE 183 LAMEA Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 184 LAMEA Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 185 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 186 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 187 LAMEA Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 188 LAMEA Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 189 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 190 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 191 LAMEA Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 192 LAMEA Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 193 LAMEA Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 194 LAMEA Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 195 LAMEA Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 196 LAMEA Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 197 LAMEA Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 198 LAMEA Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Brazil Insomnia Market, 2018 - 2021, USD Million
  • TABLE 200 Brazil Insomnia Market, 2022 - 2028, USD Million
  • TABLE 201 Brazil Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 202 Brazil Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 203 Brazil Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 204 Brazil Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 205 Argentina Insomnia Market, 2018 - 2021, USD Million
  • TABLE 206 Argentina Insomnia Market, 2022 - 2028, USD Million
  • TABLE 207 Argentina Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 208 Argentina Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 209 Argentina Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 210 Argentina Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 211 UAE Insomnia Market, 2018 - 2021, USD Million
  • TABLE 212 UAE Insomnia Market, 2022 - 2028, USD Million
  • TABLE 213 UAE Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 214 UAE Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 215 UAE Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 216 UAE Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 217 Saudi Arabia Insomnia Market, 2018 - 2021, USD Million
  • TABLE 218 Saudi Arabia Insomnia Market, 2022 - 2028, USD Million
  • TABLE 219 Saudi Arabia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 220 Saudi Arabia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 221 Saudi Arabia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 222 Saudi Arabia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 223 South Africa Insomnia Market, 2018 - 2021, USD Million
  • TABLE 224 South Africa Insomnia Market, 2022 - 2028, USD Million
  • TABLE 225 South Africa Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 226 South Africa Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 227 South Africa Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 228 South Africa Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 229 Nigeria Insomnia Market, 2018 - 2021, USD Million
  • TABLE 230 Nigeria Insomnia Market, 2022 - 2028, USD Million
  • TABLE 231 Nigeria Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 232 Nigeria Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 233 Nigeria Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 234 Nigeria Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 235 Rest of LAMEA Insomnia Market, 2018 - 2021, USD Million
  • TABLE 236 Rest of LAMEA Insomnia Market, 2022 - 2028, USD Million
  • TABLE 237 Rest of LAMEA Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 238 Rest of LAMEA Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 239 Rest of LAMEA Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 240 Rest of LAMEA Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 241 Key Information - Eisai Co., Ltd.
  • TABLE 242 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 243 Key Information - Vanda Pharmaceuticals, Inc.
  • TABLE 244 Key Information - Cadila Healthcare Ltd.
  • TABLE 245 Key Information - Sanofi S.A.
  • TABLE 246 key Information - Merck GrouP
  • TABLE 247 Key Information - Pfizer, Inc.
  • TABLE 248 key information - Viatris, Inc.
  • TABLE 249 Key Information - Currax Pharmaceuticals LLC
  • TABLE 250 Key Information - Purdue Pharma L.P.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Insomnia Market share by Distribution Channel, 2021
  • FIG 3 Global Insomnia Market share by Distribution Channel, 2028
  • FIG 4 Global Insomnia Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 5 Global Insomnia Market share by Therapy Type, 2021
  • FIG 6 Global Insomnia Market share by Therapy Type, 2028
  • FIG 7 Global Insomnia Market by Therapy Type, 2018 - 2028, USD Million
  • FIG 8 Global Insomnia Market share by Region, 2021
  • FIG 9 Global Insomnia Market share by Region, 2028
  • FIG 10 Global Insomnia Market by Region, 2018 - 2028, USD Million
  • FIG 11 Recent strategies and developments: Eisai Co., Ltd.
  • FIG 12 Recent strategies and developments: Currax Pharmaceuticals LLC